Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned
- 1 December 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (6), 1152-1153
- https://doi.org/10.1111/bjd.19489
Abstract
Recently, Colmenero et al (1) demonstrated, by immunohistochemistry, the presence of SARS‐CoV‐2 in endothelial cells of skin biopsy specimens of chilblains in seven patients. These results raise some questions: The presence of the virus at cutaneous and vascular levels in otherwise asymptomatic patients with negative RT‐PCR is unexpected. Vascular damage by direct viral effect is expected to be a sign of severity. It is also surprising that only feet are affected.This publication has 4 references indexed in Scilit:
- SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric casesBritish Journal of Dermatology, 2020
- Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicJAMA Dermatology, 2020
- Electron microscopy of SARS-CoV-2: a challenging taskThe Lancet, 2020
- Ultrastructural Characterization of SARS CoronavirusEmerging Infectious Diseases, 2004